These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7497536)

  • 1. Polymyalgia rheumatica and giant cell arteritis.
    Cimmino MA; Salvarani C
    Baillieres Clin Rheumatol; 1995 Aug; 9(3):515-27. PubMed ID: 7497536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis.
    Kyle V
    Baillieres Clin Rheumatol; 1991 Dec; 5(3):475-84. PubMed ID: 1807822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
    Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
    Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification/diagnostic criteria for GCA/PMR.
    Hunder GG
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S4-5. PubMed ID: 10948747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
    Hazleman B
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S29-31. PubMed ID: 10948756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L; Spiera R
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Giant cell arteritis and polymyalgia rheumatica: diagnostic criteria].
    Marie I
    Rev Med Interne; 2013 Jul; 34(7):403-11. PubMed ID: 23498714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.
    Myklebust G; Gran JT
    Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica.
    Zhang Y; Wang D; Chu X; Zhang W; Zeng X
    Ir J Med Sci; 2019 May; 188(2):713-720. PubMed ID: 30251177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Giant cell arteritis and polymyalgia rheumatica: diagnosis and evolution of 90 cases].
    Rivero Puente A; Berasategui Calderón JI; Murie Carrillo De Albornoz JM; Rivero Marcotegui M; García-Bragado Acín F
    An Med Interna; 2001 Apr; 18(4):191-4. PubMed ID: 11496538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymyalgia rheumatica. Clinical histological study of 46 cases].
    Gerber N; Vernon-Roberts B
    Z Rheumatol; 1977; 36(9-10):275-84. PubMed ID: 930423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis.
    Bornstein G; Barshack I; Koren-Morag N; Ben-Zvi I; Furie N; Grossman C
    Clin Rheumatol; 2018 Oct; 37(10):2819-2824. PubMed ID: 29549493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
    Front Immunol; 2019; 10():1981. PubMed ID: 31507597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.
    Liozon E; Ouattara B; Rhaiem K; Ly K; Bezanahary H; Loustaud V; Letellier P; Drouet M; Vidal E
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S89-94. PubMed ID: 19646354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyalgia rheumatica and giant cell arteritis: recent data and current situation].
    Announ N; Guerne PA
    Rev Med Suisse; 2008 Mar; 4(149):696-8, 701. PubMed ID: 18472729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.